Pinned Tweet
This is an important moment in the field of VTE. Years of physician collaboration, R&D innovation, and an incredible team of people have made this possible! Excited to introduce the most powerful and advanced mechanical thrombectomy system on the market, ⚡️Lightning Flash⚡️ – at San Francisco, CA
Shruthi Narayan retweeted
Replying to @JayMathewsMD
@JayMathewsMD @em_ccmdoc and @patrickmuckmd closing off our #HighRiskPE session with a lively debate looking at catheter based options vs systemic lytics vs surgical embolectomy in these deteriorating patients #PERT2026
Shruthi Narayan retweeted
“If someone would have told me years ago that we would have 3 positive RCTs for endovascular treatment of PE within 12-18 months, I wouldn’t have believed you. We are in the golden age of advanced therapies for PE” -Dr Robert Lookstein, MD
Shruthi Narayan retweeted
Live @SIRspecialists now that we have published results for STORM-PE and HI-PEITHO there is growing consensus that endovascular therapy should be offered to most ESC Intermediate High Risk or AHA-C3 patients to rapidly improve RV function and prevent clinical deterioration.
Shruthi Narayan retweeted
US HCPs: Single setting PE and venous thrombectomy completed by Dr. Wiske with Flash 3.0 technology. #CAVT #LightningFlash #SingleSetting
Rx only. Risk: peninc.info/risk Clinical results may vary.
Shruthi Narayan retweeted
That’s a wrap for the inaugural @clotsheadtotoe ! It was amazing to participate & witness multidisciplinary conversations around thrombus management #headtotoe! What a stellar faculty at the one & only conference focused solely on CLOTS & that too at the happiest place on Earth!
Shruthi Narayan retweeted
Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes from the STORM-PE Trial | Circulation ahajournals.org/doi/10.1161/…
Shruthi Narayan retweeted
Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE dlvr.it/TNvFWh
Shruthi Narayan retweeted
Honored to work on this incredible project. Thank you so much to all the sites and investigators around the world. Looking forward to sharing the data later this year. @PERTConsortium @SIRspecialists @SCAI @VascularSVS @SVM_tweets
STORM-PE, a pivotal clinical trial, has completed patient enrollment. Read more here: peninc.info/45mjkQt
#STORMPE #CAVT #MedTech #MedDevice
Shruthi Narayan retweeted
Mechanical thrombectomy for DMVOs is gaining traction! In a multicenter study of 102 patients, the RED 43 catheter was found to be safe and effective for distal aspiration. bit.ly/4jNHWFE @Nickkhat
#Stroke #DMVO #Thrombectomy #EndovascularTherapy #NeuroIR #Neurointervention
Shruthi Narayan retweeted
Live @PenVascular #STORM-PE investigators meeting with my global Co-PI @RosovskyRachel ….looking forward to completing the first RCT of #CAVT vs #SOC for intermediate-risk PE @SIRspecialists @SCAI @VascularSVS @SVM_tweets @ASH_hematology @PERTConsortium
Shruthi Narayan retweeted
US HCPs: Congrats to @ic_cooper on this recent PE case utilizing the #Element sheath with #HemoLock technology! Great results with #LightningFlash 2.0 ⚡ #LeadWithCAVT
Rx only. Risk info: peninc.info/risk Clinical results may vary
Outstanding High risk Pulmonary Embolism case with Penumbra Flash and their new Hemolock sheath! Completed case in 18 minutes and patient did amazing! #PERT #hemolock #element #clotbusters
Shruthi Narayan retweeted
Best science of the year happening at #PERT2024. Come for the science, stay for the game show. First up, @JonnyMoriarty detailing the outcomes of the first 300 patients in STRIKE-PE
Shruthi Narayan retweeted
Join our Lunch Symposium tomorrow to hear #TheCompletePEStory with a dive into clinical evidence and #CAVT technology for the treatment of PE with Drs. @t_intheleadcoat, Suhail Dohad, @roblookstein, @RosovskyRachel, and @sanjum
Shruthi Narayan retweeted
Join us on June 22nd to hear Dr. Thomas Maldonado discuss the benefits of endovascular first and the 12-months results from the STRIDE Study! #LightningBolt7 #CAVT #VAM24
Shruthi Narayan retweeted
Very excited to support this study and #STORM-PE to advance the prospective science for treatment of Acute PE @SIRspecialists @SCAI @VascularSVS @SVM_tweets
Shruthi Narayan retweeted
PE with new FLASH 2.0 for the win!
From Non-rebreather —>97% on room air,
PA pressure drop 44–>19mm
& Flouro time 11 mins. At my age I like PE cases under 40 minutes ! #speedyPE #CAVT
@roblookstein @keithppereira @t_intheleadcoat @vaheesanIR @SIRspecialists
Shruthi Narayan retweeted
STRIKE-PE data drop: first 150 patients demonstrating improved RV function, low adverse events & improved dyspnoea & QOL! More evidence for PE patients jvir.org/article/S1051-0443%… @SIRspecialists @PERTConsortium @UCLAHealth @uclaVIR @JVIRmedia
Shruthi Narayan retweeted
🎉 EMBOLIZE, a collab b/w @SIRspecialists Foundation & @VIVAPhysicians, in partnership w/ @penumbrainc—a pioneering trial addressing pelvic pain via pelvic venous disease—will be led by national co-PIs @RonaldWinokurMD & @GSalazar_MD. CONGRATULATIONS! 🎉
sirweb.org/media-and-pubs/me…
Shruthi Narayan retweeted
During totality 🌑🌒, we experienced our own total eclipse of the heart (or pulmonary arteries) and treated in a Flash ⚡️ @PenVascular




































